SRC and idiopathic pulmonary fibrosis: In the co-culture model, saracatinib had an effect on both sphere formation and fibroblast proliferation suggesting that combined SRC and ABL inhibition by saracatinib may disrupt the profibrotic HV-ABCs crosstalk between IPF-ABCs and fibroblasts.